Efficacy of plasmapheresis in the treatment of refractory toxic epidermal necrolysis–like acute cutaneous lupus erythematosus

1 Paradela S Martinez-Gomez W Fernandez-Jorge B . Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus. Lupus 2007; 16: 741 – 745 .

2 Ting W Stone MS Racila D Scofield RH Sontheimer RD . Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus and the spectrum of the acute syndrome of apoptotic pan-epidermolysis (ASAP): a case report, concept review and proposal for new classification of lupus erythematosus vesiculobullous skin lesions. Lupus 2004; 13: 941 – 950 .

3 Mandelcorn R Shear NH . Lupus-associated toxic epidermal necrolysis: a novel manifestation of lupus? J Am Acad Dermatol 2003; 48: 525 – 529 .

4 Mutasim DF . Severe subacute cutaneous lupus erythematosus presenting with generalized erythroderma and bullae. J Am Acad Dermatol 2003; 48: 947 – 949 .

5 Bielsa I Herrero C Font J Mascaro JM . Lupus erythematosus and toxic epidermal necrolysis. J Am Acad Dermatol 1987; 16: 1265 – 1267 .

6 Perera GK Black MM McGibbon DH . Bullous subacute cutaneous lupus erythematosus. Clin Exp Dermatol 2004; 29: 265 – 267 .

7 Chave TA Mortimer NJ Sladden MJ Hall AP Hutchinson PE . Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol 2005; 153: 241 – 253 .

8 Bamichas G Natse T Christidou F . Plasma exchange in patients with toxic epidermal necrolysis. Ther Apher 2002; 6: 225 – 228 .

9 Egan CA Grant WJ Morris SE Saffle JR Zone JJ . Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis. J Am Acad Dermatol 1999; 40: 458 – 461 .

10 Viard I Wehrli P Bullani R . Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282: 490 – 493 .